1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Ser/Thr Kinase

Ser/Thr Kinase (丝氨酸/苏氨酸激酶)

Protein Serine-Threonine Kinase

Ser/Thr Kinase belongs to the eukaryotic protein kinase (ePK) superfamily and can use ATP to phosphorylate the hydroxyl group of serine or threonine residues in the kinase recognition amino acid sequence. The widely known anticancer targets in the Ser/Thr Kinase family are protein kinase C (PKC) and cyclin-dependent kinases (CDKs). There are two types of Ser/Thr Kinase: one is a kinase that phosphorylates receptor molecules, i.e., receptor protein serine/threonine kinases, such as activated receptor kinases and transforming growth factor β receptor kinases; the other is a kinase that acts as an intracellular signal transduction protein. The latter can phosphorylate several key targets of multiple signaling pathways and affect a variety of biological functions including growth, differentiation, cell cycle progression, and metabolism. This family contains several different groups of kinases, including (1) the CK group of kinases: casein kinases; (2) the AGC group: the kinases protein kinase A (PKA), protein kinase B (PKB or v-akt murine thymoma viral oncogene homolog 1: AKT1), and protein kinase C (PKC); (3) the CAMK group of kinases: Ca2+/calmodulin-dependent kinases; (4) the CMGC group of kinases: mos/raf kinases, mitogen-activated kinases (MAPKs), cyclin-dependent kinases (CDKs), and glycogen synthase kinases (GSKs); and (5) the STE group of kinases: homologs of yeast sterile kinases 7, 11, and 20 kinases.Ser/Thr Kinase family regulates the glucocorticoid receptor (GR), a nuclear hormone receptor superfamily protein. For example, MAPK, CDK, PKB/AKT1 and GSK3β can phosphorylate GR at specific residues; PKA, AKT1, PKC, MAPK, AMPK and mTOR can additionally phosphorylate other kinases and/or transcriptional cofactors associated with DNA-associated GR to indirectly regulate GR. It is worth mentioning that p38 MAPK in the MAPK family regulates serine phosphorylation of GR through upstream MAP2K2/4, while another JNK inhibits GR transcriptional activity by enhancing the nuclear export of the receptor[1][2].

Ser/Thr Kinase 相关产品 (32):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-170574
    CQ627 Degrader
    CQ627 是一种靶向降解 RIOK2 的分子胶 (Molecular Glues)。CQ627 能有效地通过招募 E3 泛素连接酶 RNF126,在 MOLT4 白血病细胞系中通过泛素-蛋白酶体系统 (UPS) 诱导 RIOK2 的降解,其 DC50 值为 410 nM。CQ627 剂量依赖性地诱导 MOLT4 白血病细胞系凋亡 (Apoptosis),在 G2/M 阶段阻断其细胞周期,且在多种癌症细胞系中展示出抗增殖活性。CQ627 也在 MOLT4 异种移植小鼠模型中展示出体内抗癌活性。
    CQ627
  • HY-172241
    Tapencarium Inhibitor
    Tapencarium (RZL-012) 是一种丝氨酸/苏氨酸激酶 (serine/threonine kinase) 抑制剂。Tapencarium 可减少皮下脂肪体积。Tapencarium 有望用于脂肪相关疾病,如 Dercum 病和美容应用的研究。
    Tapencarium
  • HY-10424A
    Milciclib maleate Inhibitor
    Milciclib (PHA-848125) maleate 是一种细胞周期依赖性激酶抑制剂,可抑制黑色素瘤细胞生长并调节参与细胞周期调控的基因表达。Milciclib maleate 已被证明可显著影响各种基因的表达,包括下调 PTTG1,从而发挥其抗增殖活性。Milciclib maleate 与 PTTG1 沉默相结合可增强 p53 突变黑色素瘤细胞对抑制的敏感性。
    Milciclib maleate
  • HY-156792
    RIOK2-IN-1 Inhibitor
    RIOK2-IN-1 (com 4) 是有效的选择性 RIOK2 抑制剂 (Kd=150 nM),但细胞活性较低 (IC50=14,600 nM)。而 RIOK2 是一种与多种人类癌症有关的非典型激酶,参与核糖体成熟和细胞周期进展。以 RIOK2-IN-1 为先导化合物的改进得到的小分子抑制剂 CQ211 (HY-147655) 具有良好的体内外活性,抑制 MKN-1 和 HT-29 癌细胞的增殖,并在小鼠异种移植 MKN-1 模型中抑制肿瘤进展。
    RIOK2-IN-1
  • HY-173186
    TLK1-IN-1 Inhibitor
    TLK1-IN-1 (Compound 5n) 是一种 TLK1 抑制剂,对 TLK1BIC50 为 7.2 μM ,对 LNCaP 细胞的 GI50 为 2.7 μM。TLK1-IN-1 诱导癌细胞 DNA 损伤和凋亡 (Apoptosis),可用于前列腺癌领域的研究。
    TLK1-IN-1
  • HY-E70788
    BARK1 Recombinant Human Active Protein Kinase
    BARK1 Recombinant Human Active Protein Kinase 是一种膜 LRR-RLK (富含亮氨酸重复受体样激酶) 蛋白,可特异性结合 BAK1 及其同源物。
    BARK1 Recombinant Human Active Protein Kinase
  • HY-171291
    Protein kinase inhibitor 14 Inhibitor
    Protein kinase inhibitor 14 (Compound 13) 对多种丝氨酸/苏氨酸激酶和受体/非受体酪氨酸激酶表现出抑制作用。
    Protein kinase inhibitor 14
  • HY-171293
    Protein kinase inhibitor 15 Inhibitor
    Protein kinase inhibitor 15 (Compound A.35.3) 对多种 Ser/Thr 激酶或受体/非受体酪氨酸激酶表现出抑制活性。
    Protein kinase inhibitor 15
  • HY-156465
    RIOK2-IN-2 Inhibitor
    RIOK2-IN-2 (8) 是RIOK2 的抑制剂,其在MKN-1 和MOLT4 的IC50 值分别为3.02 μM 和5.34 μM。
    RIOK2-IN-2
  • HY-169587
    Protein kinase G inhibitor-3 Inhibitor
    Protein kinase G inhibitor-3 (Compound 177) 是一种分枝杆菌丝氨酸/苏氨酸蛋白激酶抑制剂。Protein kinase G inhibitor-3 可用于分枝杆菌感染相关疾病的研究。
    Protein kinase G inhibitor-3
  • HY-171294
    Protein kinase inhibitor 16 Inhibitor
    Protein kinase inhibitor 16 对多种 Ser/Thr 激酶或受体/非受体酪氨酸激酶表现出抑制活性。
    Protein kinase inhibitor 16
  • HY-171276
    Anti-neuroinflammation agent 3 Inhibitor
    Anti-neuroinflammation agent 3 (Compound A.10.3) 对多种 Ser/Thr 激酶或受体/非受体酪氨酸激酶表现出抑制活性。
    Anti-neuroinflammation agent 3